by Dr. Andrew A. Kramer | Jan 16, 2020 | News
Prescient has teamed up with OBS Medical, LTD to form a joint venture company called ViSIG Health, LLC. ViSIG will combine Prescient’s rSIGNIPHY technology with OBS’ Visensia solution to create a novel early warning system tool for intensive care units. Clinical...
by Dr. Andrew A. Kramer | Dec 31, 2019 | News
In Q4 2019 Prescient submitted a patent application for its rSIGNIPHY solution. rSIGNIPHY is an evolutionary step from SIGNIPHY in that it yields continuously updated predictions of patient mortality in near-real time. Click here for more information on this amazing...
by Dr. Andrew A. Kramer | Oct 4, 2016 | Healthcare Data, Methodology
Suppose you’re about to undergo a complicated surgical procedure to remove an embolism in your carotid artery. The chief surgeon tells you that he has a new high-powered laser that is great at dissolving clots. Sounds great, right? But when you ask if the operation is...
by Dr. Andrew A. Kramer | Aug 16, 2016 | Methodology
Everyone who wants to delve into predictive modeling in medicine starts out studying linear regression. After learning the basics we’re told that that this type of model is unrealistic, as associations between biologic characteristics and health outcomes are almost...
by Dr. Andrew A. Kramer | Aug 4, 2016 | Prescient News
At the SAS Global Forum in April CEO Dr. James Goodnight unveiled a stunning new platform for SAS, called SAS Viya. The demos of Viya were amazing, but could the actual product stand up to rigorous testing by power users? Prescient’s Dr. Andrew Kramer got to do an...
Recent Comments